These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 12224404)

  • 21. Comparison of [(18)F]altanserin and [(18)F]deuteroaltanserin for PET imaging of serotonin(2A) receptors in baboon brain: pharmacological studies.
    Staley JK; Van Dyck CH; Tan PZ; Al Tikriti M; Ramsby Q; Klump H; Ng C; Garg P; Soufer R; Baldwin RM; Innis RB
    Nucl Med Biol; 2001 Apr; 28(3):271-9. PubMed ID: 11323237
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Central serotonergic S2 binding in Papio anubis measured in vivo with N-omega-[18F]fluoroethylketanserin and PET.
    Moerlein SM; Perlmutter JS
    Neurosci Lett; 1991 Feb; 123(1):23-6. PubMed ID: 2062450
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reproducibility of 5-HT2A receptor measurements and sample size estimations with [18F]altanserin PET using a bolus/infusion approach.
    Haugbøl S; Pinborg LH; Arfan HM; Frøkjaer VM; Madsen J; Dyrby TB; Svarer C; Knudsen GM
    Eur J Nucl Med Mol Imaging; 2007 Jun; 34(6):910-5. PubMed ID: 17195073
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multicompartmental study of fluorine-18 altanserin binding to brain 5HT2 receptors in humans using positron emission tomography.
    Biver F; Goldman S; Luxen A; Monclus M; Forestini M; Mendlewicz J; Lotstra F
    Eur J Nucl Med; 1994 Sep; 21(9):937-46. PubMed ID: 7995287
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fluorine-18-altanserin: a radioligand for the study of serotonin receptors with PET: radiolabeling and in vivo biologic behavior in rats.
    Lemaire C; Cantineau R; Guillaume M; Plenevaux A; Christiaens L
    J Nucl Med; 1991 Dec; 32(12):2266-72. PubMed ID: 1744713
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Binding characteristics of the 5-HT2A receptor antagonists altanserin and MDL 100907.
    Kristiansen H; Elfving B; Plenge P; Pinborg LH; Gillings N; Knudsen GM
    Synapse; 2005 Dec; 58(4):249-57. PubMed ID: 16206185
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced binding of [18F]altanserin to serotonin type 2A receptors in aging: persistence of effect after partial volume correction.
    Meltzer CC; Smith G; Price JC; Reynolds CF; Mathis CA; Greer P; Lopresti B; Mintun MA; Pollock BG; Ben-Eliezer D; Cantwell MN; Kaye W; DeKosky ST
    Brain Res; 1998 Nov; 813(1):167-71. PubMed ID: 9824691
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of serotonin release capacity in the human brain using dexfenfluramine challenge and [18F]altanserin positron emission tomography.
    Quednow BB; Treyer V; Hasler F; Dörig N; Wyss MT; Burger C; Rentsch KM; Westera G; Schubiger PA; Buck A; Vollenweider FX
    Neuroimage; 2012 Feb; 59(4):3922-32. PubMed ID: 21996132
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [18F]altanserin binding to human 5HT2A receptors is unaltered after citalopram and pindolol challenge.
    Pinborg LH; Adams KH; Yndgaard S; Hasselbalch SG; Holm S; Kristiansen H; Paulson OB; Knudsen GM
    J Cereb Blood Flow Metab; 2004 Sep; 24(9):1037-45. PubMed ID: 15356424
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cluster analysis in kinetic modelling of the brain: a noninvasive alternative to arterial sampling.
    Liptrot M; Adams KH; Martiny L; Pinborg LH; Lonsdale MN; Olsen NV; Holm S; Svarer C; Knudsen GM
    Neuroimage; 2004 Feb; 21(2):483-93. PubMed ID: 14980551
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sex difference in 5HT2 receptor in the living human brain.
    Biver F; Lotstra F; Monclus M; Wikler D; Damhaut P; Mendlewicz J; Goldman S
    Neurosci Lett; 1996 Feb; 204(1-2):25-8. PubMed ID: 8929969
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreased hippocampal 5-HT(2A) receptor binding in older depressed patients using [18F]altanserin positron emission tomography.
    Sheline YI; Mintun MA; Barch DM; Wilkins C; Snyder AZ; Moerlein SM
    Neuropsychopharmacology; 2004 Dec; 29(12):2235-41. PubMed ID: 15367923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kinetic analysis of [
    Pauwelyn G; Vlerick L; Dockx R; Verhoeven J; Dobbeleir A; Bosmans T; Peremans K; Vanhove C; Polis I; De Vos F
    BMC Vet Res; 2019 Nov; 15(1):415. PubMed ID: 31752848
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantification of 5-HT2A receptors in the human brain using [18F]altanserin-PET and the bolus/infusion approach.
    Pinborg LH; Adams KH; Svarer C; Holm S; Hasselbalch SG; Haugbøl S; Madsen J; Knudsen GM
    J Cereb Blood Flow Metab; 2003 Aug; 23(8):985-96. PubMed ID: 12902843
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measurement of changes in endogenous serotonin level by positron emission tomography with [
    Ikoma Y; Takuwa H; Nishino A; Maeda J; Kawamura K; Obata T; Zhang MR; Higuchi M; Suhara T
    Ann Nucl Med; 2021 Aug; 35(8):955-965. PubMed ID: 34101154
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Time-efficient and convenient synthesis of [(18)F]altanserin for human PET imaging by a new work-up procedure.
    Massarweh G; Kovacevic M; Rosa-Neto P; Evans AC; Diksic M; Schirrmacher R
    Appl Radiat Isot; 2009 Nov; 67(11):2040-3. PubMed ID: 19692252
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patients with obsessive-compulsive disorder have increased 5-HT2A receptor binding in the caudate nuclei.
    Adams KH; Hansen ES; Pinborg LH; Hasselbalch SG; Svarer C; Holm S; Bolwig TG; Knudsen GM
    Int J Neuropsychopharmacol; 2005 Sep; 8(3):391-401. PubMed ID: 15801987
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 5-HT1A and 5-HT2A receptor mRNAs and binding site densities are differentially altered in schizophrenia.
    Burnet PW; Eastwood SL; Harrison PJ
    Neuropsychopharmacology; 1996 Nov; 15(5):442-55. PubMed ID: 8914117
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Widespread increases of cortical serotonin type 2A receptor availability after hormone therapy in euthymic postmenopausal women.
    Moses-Kolko EL; Berga SL; Greer PJ; Smith G; Cidis Meltzer C; Drevets WC
    Fertil Steril; 2003 Sep; 80(3):554-9. PubMed ID: 12969697
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validation and quantification of [18F]altanserin binding in the rat brain using blood input and reference tissue modeling.
    Riss PJ; Hong YT; Williamson D; Caprioli D; Sitnikov S; Ferrari V; Sawiak SJ; Baron JC; Dalley JW; Fryer TD; Aigbirhio FI
    J Cereb Blood Flow Metab; 2011 Dec; 31(12):2334-42. PubMed ID: 21750562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.